Advertisement
Advertisement
U.S. markets close in 41 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.6200-0.1300 (-7.43%)
As of 03:17PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close1.7500
Open1.7600
Bid1.6300 x 1000
Ask1.6400 x 3200
Day's Range1.6000 - 1.7600
52 Week Range1.6000 - 9.5400
Volume332,741
Avg. Volume655,622
Market Cap75.409M
Beta (5Y Monthly)0.87
PE Ratio (TTM)N/A
EPS (TTM)-0.1770
Earnings DateMar 23, 2022 - Mar 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
2% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CRVS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Corvus Pharmaceuticals, Inc.
    Daily – Vickers Top Buyers & Sellers for 05/06/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    9 months agoArgus Research
View more
Advertisement
Advertisement